Keyword: Active Pharmaceutical Ingredients (APIs)


Teva Intends to Divest API Business

02.02.2024 -

Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of...


Olon to Open New High Potency API Suite in US

29.01.2024 -

Olon Group is building a state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) suite at its Olon USA site in Concord, Ohio. This expands the company's...


EuroAPI Collaborates with Contract Research Organization SpiroChem

26.01.2024 -

Active pharmaceutical ingredients manufacturer EuroAPI has started a collaboration with Basel, Switzerland-headquartered SpiroChem, a contract research organization (CRO)...


Lucas Sauer-Jones Appointed as Vice President & General Manager of Veranova’s New England Sites

14.12.2023 -

US API maker Veranova has appointed Lucas Sauer-Jones as the company’s vice president & general manager, New England. He will be responsible for Veranova’s sites in...


Novo Nordisk to Invest €5.6 Billion in Expansion of API Production in Denmark

13.11.2023 -

Danish drugmaker Novo Nordisk plans to invest more than 42 billion Danish kroner (about €5.6 billion) starting in 2023 to expand existing manufacturing facilities at the...


Olon to Nearly Double Production Capacity of Indian Site

10.11.2023 -

Olon, an Italian CDMO and API producer of active pharmaceutical ingredients (APIs), plans to invest €10 million in a multi-year expansion of its production site in Mahad...


Noramco Acquires Drug Product Business Unit from Cambrex

06.11.2023 -

Noramco, a US producer of active pharmaceutical ingredients (APIs), has completed the acquisition of the Cambrex drug product business unit previously known as Halo...


EuroAPI Announces New Governance

26.10.2023 -

EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane...